Skip to main content
Year archive

Cellectis — 2020 filings

All 106 regulatory filings released by Cellectis (ALCLS) in 2020, sourced directly from the official regulator.

106 Filings
2020 Period
2020 filings (106)
Filing Released Lang
Regulatory Filings 2020
Regulatory Filings
2020-12-29 English
FORM 6-K
Foreign Filer Report
2020-12-29 English
FORM 6-K
Foreign Filer Report
2020-12-16 English
Cellectis annonce le retrait de son offre d’ADS
Share Issue/Capital Change
2020-12-16 French
Cellectis Announces Withdrawal of Follow-On Offering
Share Issue/Capital Change
2020-12-16 English
424B5
Prospectus
2020-12-15 English
FWP
Regulatory Filings
2020-12-14 English
FORM 6-K
Foreign Filer Report
2020-12-14 English
Cellectis annonce le lancement d’une nouvelle offre d’ADS
Share Issue/Capital Change
2020-12-14 French
Cellectis Announces Launch of Follow-On Offering
Share Issue/Capital Change
2020-12-14 English
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2020-12-08 French
Monthly information on share capital and company voting rights
Share Issue/Capital Change
2020-12-08 English
FORM 6-K
Foreign Filer Report
2020-12-07 English
Cellectis Reports Preliminary Results from its Phase 1 BALLI-01 Study of UCART22 in R/R Adult B-ALL at American Society of Hematology (ASH) Annual Meeting
Earnings Release FY 2020
2020-12-05 English
American Society of Hematology (ASH) : Cellectis dévoile des résultats préliminaires de son essai clinique de Phase I BALLI-01 évaluant UCART22 chez l’adulte atteint de LLA à cellules B en rechute ou
Earnings Release FY 2020
2020-12-05 French
FORM 6-K
Foreign Filer Report
2020-11-18 English
FDA Lifts Clinical Hold on MELANI-01 Study Evaluating Cellectis’ Product Candidate UCARTCS1 in Multiple Myeloma
Regulatory Filings
2020-11-18 English
FORM 6-K
Foreign Filer Report
2020-11-16 English
Cellectis Appoints Pharma HR Leader Kyung Nam-Wortman as Executive Vice President, Chief Human Resources Officer
Board/Management Information
2020-11-16 English
Cellectis nomme Kyung Nam-Wortman, experte de l’industrie pharmaceutique, Vice-Présidente Exécutive, Directrice des Ressources Humaines
Board/Management Information
2020-11-16 French
SC 13G
Major Shareholding Notification
2020-11-10 English
Monthly information on share capital and company voting rights
Declaration of Voting Results & Voting Rights Announcements
2020-11-06 English
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2020-11-06 French
FORM 6-K
Foreign Filer Report
2020-11-05 English
FORM 6-K
Foreign Filer Report
2020-11-05 English
Cellectis publie ses résultats financiers pour le troisième trimestre et pour les neuf premiers mois de l’année 2020
Earnings Release 9M 2020
2020-11-05 French
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2020
Earnings Release 9M 2020
2020-11-05 English
FORM 6-K
Foreign Filer Report
2020-11-05 English
FORM 6-K
Foreign Filer Report
2020-11-04 English
American Society of Hematology (ASH) Abstract Shows Initial Anti-Leukemic Activity of UCART22 in BALLI-01 Phase 1 Study in R/R Adult B-ALL
Regulatory Filings
2020-11-04 English
SC 13D/A
Major Shareholding Notification
2020-10-23 English
Cellectis to Hold Third Quarter 2020 Earnings Call on Friday, November 6, 2020 at 8:00AM EST
Earnings Release Q3 2020
2020-10-21 English
Cellectis organise une conférence téléphonique pour présenter ses résultats financiers du troisième trimestre 2020 le vendredi 6 novembre à 14h00 CET
Report Publication Announcement
2020-10-21 French
FORM 4 SUBMISSION
Director's Dealing
2020-10-20 English
6-K
Foreign Filer Report
2020-10-16 English
FORM 6-K
Foreign Filer Report
2020-10-16 English
Calyxt annonce une offre directe enregistrée aux États-Unis de 15 millions de dollars
Capital/Financing Update
2020-10-16 French
Calyxt Announces $15 Million Registered Direct Offering
Capital/Financing Update
2020-10-16 English
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2020-10-07 French
Monthly information on share capital and company voting rights
Share Issue/Capital Change
2020-10-07 English
6-K
Foreign Filer Report
2020-10-01 English
6-K/A
Foreign Filer Report
2020-09-09 English
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Share Issue/Capital Change
2020-09-07 French
Monthly information on share capital and company voting rights
Share Issue/Capital Change
2020-09-07 English
Cellectis to Participate in Upcoming Investor Conferences
Regulatory Filings
2020-09-02 English
FORM 6-K
Foreign Filer Report
2020-08-05 English
FORM 6-K
Foreign Filer Report
2020-08-05 English
Cellectis publie ses résultats financiers pour le deuxième trimestre et le premier semestre 2020
Earnings Release H1 2020
2020-08-05 French
Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2020
Earnings Release H1 2020
2020-08-05 English
SC 13D
Major Shareholding Notification
2020-08-04 English
Cellectis organise une conférence téléphonique pour présenter ses résultats financiers du second trimestre 2020 le jeudi 6 août à 13h30 CET
Report Publication Announcement
2020-07-29 French
Cellectis to Hold Second Quarter 2020 Earnings Call on Thursday, August 6, 2020 at 7:30AM EDT
Earnings Release Q2 2020
2020-07-29 English
Franchissement de seuils
Declaration of Voting Results & Voting Rights Announcements
2020-07-29 French
FORM 6-K
Foreign Filer Report
2020-07-21 English
Cellectis nomme Dr Steve Doares, vétéran de l’industrie biopharmaceutique, Vice-Président Sénior de son Manufacturing aux États-Unis
Board/Management Information
2020-07-21 French
Cellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US Manufacturing
Board/Management Information
2020-07-21 English
Monthly information on share capital and company voting rights
Regulatory Filings
2020-07-11 English
SC 13D/A
Major Shareholding Notification
2020-07-10 English
FORM 6-K
Foreign Filer Report
2020-07-06 English
Pour se concentrer pleinement sur Cellectis, André Choulika se retire du Conseil d'Administration de Calyxt
Board/Management Information
2020-07-06 French
To Fully Focus on Cellectis, Dr. André Choulika Retires From Calyxt’s Board of Directors
Board/Management Information
2020-07-06 English
FORM 6-K
Foreign Filer Report
2020-07-06 English
Cellectis annonce la suspension de l’étude clinique MELANI-01
Regulatory Filings
2020-07-06 French
Cellectis Reports Clinical Hold Placed on MELANI-01 Study
Legal Proceedings Report
2020-07-06 English
6-K
Foreign Filer Report
2020-06-30 English
FORM 6-K
Foreign Filer Report
2020-06-30 English
Résultats de l’Assemblée Générale Mixte des Actionnaires de Cellectis S.A. du 29 juin 2020
AGM Information
2020-06-29 French
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 29, 2020
AGM Information
2020-06-29 English
FORM 6-K
Foreign Filer Report
2020-06-25 English
Cellectis publie une méthode de fabrication simplifiée pour générer des thérapies cellulaires CAR-T allogéniques ultra-pures
Regulatory Filings
2020-06-25 French
Cellectis Published Streamlined Manufacturing Method to Generate Ultrapure Allogeneic CAR T-Cell Therapies
Regulatory Filings
2020-06-25 English
F-3ASR
Regulatory Filings
2020-06-02 English
FORM 6-K
Foreign Filer Report
2020-05-18 English
6-K
Foreign Filer Report
2020-05-08 English
6-K
Foreign Filer Report
2020-05-06 English
FORM 6-K
Foreign Filer Report
2020-05-06 English
FORM 6-K
Foreign Filer Report
2020-04-29 English
FORM 6-K
Foreign Filer Report
2020-04-13 English
CELLECTIS S.A. 6-K
Foreign Filer Report
2020-03-10 English
20-F
Annual Report FY 2019
2020-03-04 English
CELLECTIS S.A. 6-K
Foreign Filer Report
2020-03-04 English
Informations privilégiées / Autres communiqués
Earnings Release Q4 2019
2020-03-04 French
Inside Information / Other news releases
Earnings Release Q4 2019
2020-03-04 English
CELLECTIS S.A. 6-K
Foreign Filer Report
2020-03-04 English
Informations privilégiées / Autres communiqués
Regulatory Filings
2020-03-04 French
Inside Information / Other news releases
Regulatory Filings
2020-03-04 English
CELLECTIS S.A. 6-K
Foreign Filer Report
2020-02-25 English
Inside Information / Other news releases
Earnings Release Q4 2019
2020-02-25 English
Informations privilégiées / Autres communiqués
Earnings Release Q4 2019
2020-02-25 French
CELLECTIS S.A. 6-K
Foreign Filer Report
2020-02-18 English
Informations privilégiées / Autres communiqués
Regulatory Filings
2020-02-18 French
Inside Information / Other news releases
Regulatory Filings
2020-02-18 English
SC 13G
Major Shareholding Notification
2020-02-14 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements
2020-02-07 French
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-07 English
Franchissement de seuil et déclaration d'intention
Major Shareholding Notification
2020-01-28 French
CELLECTIS S.A. 6-K
Foreign Filer Report
2020-01-15 English
Inside Information / Other news releases
Regulatory Filings
2020-01-15 English
Informations privilégiées / Autres communiqués
Regulatory Filings
2020-01-15 French
CELLECTIS S.A. 6-K
Foreign Filer Report
2020-01-13 English
Informations privilégiées / Autres communiqués
M&A Activity
2020-01-12 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Share Issue/Capital Change
2020-01-09 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change
2020-01-09 French
CELLECTIS S.A. 6-K
Foreign Filer Report
2020-01-06 English
Inside Information / Other news releases
Regulatory Filings
2020-01-06 English
Informations privilégiées / Autres communiqués
Regulatory Filings
2020-01-06 French